FHIR IG analytics| Package | fhir.ke.nccp |
| Resource Type | CodeSystem |
| Id | CodeSystem-ctcae-terms-cs.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/IntelliSOFT-Consulting/nccpFHIRIG/CodeSystem-ctcae-terms-cs.html |
| URL | https://nshr-uat.sha.go.ke/fhir/CodeSystem/ctcae-terms-cs |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-06-08T10:30:33+00:00 |
| Name | CTCAETermsCS |
| Title | Kenya CTCAE Adverse Event Terms Code System |
| Realm | us |
| Authority | hl7 |
| Description | NCI CTCAE v5.0 adverse event terms used in oncology toxicity grading. |
| Content | complete |
| ValueSet | ||
| fhir.ke.nccp#current | nccp-ctcae-terms-vs | Kenya CTCAE Adverse Event Terms Value Set |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem ctcae-terms-cs
This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/ctcae-terms-cs defines the following codes:
{
"resourceType": "CodeSystem",
"id": "ctcae-terms-cs",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/ctcae-terms-cs",
"version": "0.1.0",
"name": "CTCAETermsCS",
"title": "Kenya CTCAE Adverse Event Terms Code System",
"status": "active",
"experimental": false,
"date": "2026-06-08T10:30:33+00:00",
"publisher": "Digital Health Agency (DHA), Kenya",
"contact": [
{
"name": "Digital Health Agency (DHA), Kenya",
"telecom": [
{
"system": "url",
"value": "https://dha.go.ke"
},
{
"system": "email",
"value": "info@dha.go.ke"
}
]
},
{
"name": "Digital Health Agency Kenya – FHIR Team",
"telecom": [
{
"system": "email",
"value": "info@dha.go.ke",
"use": "work"
},
{
"system": "url",
"value": "https://dha.go.ke",
"use": "work"
}
]
}
],
"description": "NCI CTCAE v5.0 adverse event terms used in oncology toxicity grading.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "KE",
"display": "Kenya"
}
]
}
],
"caseSensitive": true,
"content": "complete",
"count": 30,
"concept": [
{
"code": "NAUSEA",
"display": "Nausea"
},
{
"code": "VOMITING",
"display": "Vomiting"
},
{
"code": "DIARRHOEA",
"display": "Diarrhoea"
},
{
"code": "CONSTIPATION",
"display": "Constipation"
},
{
"code": "ANOREXIA",
"display": "Anorexia / Decreased Appetite"
},
{
"code": "FATIGUE",
"display": "Fatigue"
},
{
"code": "ALOPECIA",
"display": "Alopecia"
},
{
"code": "NEUTROPENIA",
"display": "Neutropenia"
},
{
"code": "THROMBOCYTOPENIA",
"display": "Thrombocytopenia"
},
{
"code": "ANAEMIA",
"display": "Anaemia"
},
{
"code": "FEBRILE-NEUTROPENIA",
"display": "Febrile Neutropenia"
},
{
"code": "PERIPHERAL-NEUROPATHY",
"display": "Peripheral Neuropathy (Sensory)"
},
{
"code": "MOTOR-NEUROPATHY",
"display": "Peripheral Neuropathy (Motor)"
},
{
"code": "MUCOSITIS",
"display": "Mucositis / Stomatitis"
},
{
"code": "RASH",
"display": "Rash / Skin Toxicity"
},
{
"code": "HAND-FOOT-SYNDROME",
"display": "Hand-Foot Syndrome (PPE)"
},
{
"code": "HEPATOTOXICITY",
"display": "Hepatotoxicity (elevated LFTs)"
},
{
"code": "NEPHROTOXICITY",
"display": "Nephrotoxicity (elevated creatinine)"
},
{
"code": "CARDIOTOXICITY",
"display": "Cardiotoxicity (reduced LVEF)"
},
{
"code": "PERIPHERAL-OEDEMA",
"display": "Peripheral Oedema"
},
{
"code": "DYSPNOEA",
"display": "Dyspnoea"
},
{
"code": "PAIN",
"display": "Pain"
},
{
"code": "INFECTION",
"display": "Infection"
},
{
"code": "ALLERGIC-REACTION",
"display": "Allergic Reaction / Hypersensitivity"
},
{
"code": "ARTHRALGIA-MYALGIA",
"display": "Arthralgia / Myalgia"
},
{
"code": "COGNITIVE-IMPAIRMENT",
"display": "Cognitive Impairment (chemo-brain)"
},
{
"code": "HYPOTHYROIDISM",
"display": "Hypothyroidism"
},
{
"code": "COLITIS",
"display": "Immune-related Colitis"
},
{
"code": "PNEUMONITIS",
"display": "Immune-related Pneumonitis"
},
{
"code": "OTHER",
"display": "Other (specify)"
}
]
}